FDA DEVICE FACTS
SABER-XA System
Elevation Spine
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Elevation Spine SABER-XA System is indicated for intervertebral fusion in patients with DDD at one or two contiguous levels from L1 to S1. These DDD patients may also have up to Grade 1 Spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment. The SABER-XA Spacer is to be filled with autograft bone and/or allogenic bone graft composed of cancellous and/or corticocancellous bone. The Elevation Spine SABER-XA Anterior Lumbar Plate, when used with screws and without the SABER-XA spacer component, is intended for anterior screw fixation to the lumbosacral spine (L1- S1) to treat instability resulting from: fracture (including dislocation and subluxation), tumor, degenerative disc disease (as defined above), pseudoarthrosis, spondylolysis, spondylolisthesis, scoliosis, kyphosis, lordosis, spinal stenosis, or failed previous spine surgery. The Anterior Lumbar Plate is not to be used alone with Spikes, but may be used in construct with the spacer and spikes. All interbody fusion constructs of SABER-XA System are intended to be used with FDA cleared supplemental fixation.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。